secwatch.observer — SEC 8-K summary
======================================

Issuer:     Thorne Healthtech, Inc. (—)
CIK:        0001844280
Form:       8-K
Filed at:   2023-02-03T23:59:59+00:00
Accession:  0000950170-23-001743
Event type: m_and_a
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 2.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Thorne HealthTech acquires PreCon Health for $5M cash to bolster brain health portfolio
--------------------------------------------------------------------------------

- Acquired all outstanding shares of PreCon Health on Jan 31, 2023, for $5.0M in cash.
- Deal provides access to PreCon's brain health products, IP, and top-tier Medical and Scientific Advisory Board.
- Thorne and PreCon previously partnered in 2021 to launch SynaQuell and SynaQuell+ supplements.
- Thorne may pay future royalties to Eigenlyfe on certain supplement sales upon meeting profit criteria.
- Ongoing Mayo Clinic clinical trials (NCT05041192, NCT05498818) study SynaQuell's effect on brain function.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1844280/000095017023001743/0000950170-23-001743-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1844280/000095017023001743/thrn-20230131.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-001743

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer